Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate CancerMatti Annala, Kim N., Gillian Vandekerkhove et al.|Cancer Discovery|2018Cited by 520
Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate CancerAlexander W. Wyatt, Kim N., Arun Azad et al.|JAMA Oncology|2016Cited by 384
Molecular Profiling Identifies Prognostic Subgroups of Pediatric Glioblastoma and Shows Increased YB-1 Expression in TumorsDamien Faury, Nada Jabado, André Nantel et al.|Journal of Clinical Oncology|2007Cited by 219
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate CancerMatti Annala, Alexander W. Wyatt, Werner J. Struss et al.|European Urology|2017Cited by 218